Evolent Health, Inc.
US ˙ NYSE ˙ US30050B1017

Introduction

This page provides a comprehensive analysis of the known insider trading history of Shawn M Guertin. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Shawn M Guertin has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:EVH / Evolent Health, Inc. Director 0
US:CVS / CVS Health Corporation EVP & Chief Financial Officer 103,950
US:DVA / DaVita Inc. Director 1,105
US:TNET / TriNet Group, Inc. Director 8,560
US:AET / Aetna, Inc. Exec. Vice President, CFO 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Shawn M Guertin. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases EVH / Evolent Health, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EVH / Evolent Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EVH / Evolent Health, Inc. Insider Trades
Insider Sales EVH / Evolent Health, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EVH / Evolent Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EVH / Evolent Health, Inc. Insider Trades
Insider Purchases TNET / TriNet Group, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EVH / Evolent Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TNET / TriNet Group, Inc. Insider Trades
Insider Sales TNET / TriNet Group, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EVH / Evolent Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TNET / TriNet Group, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Shawn M Guertin as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-09 3 EVH Evolent Health, Inc.
No securities beneficially owned
0
2025-06-09 2025-06-05 4 EVH Evolent Health, Inc.
Class A Common Stock
A - Award 21,979 21,979
2022-04-05 2022-04-01 4 CVS CVS HEALTH Corp
Stock Option
A - Award 103,950 103,950 101.09 10,508,306 10,508,306
2021-06-02 3 CVS CVS HEALTH Corp
Common Stock
9,260
2021-06-02 2021-05-28 4 CVS CVS HEALTH Corp
Stock Option
A - Award 97,562 97,562 86.44 8,433,259 8,433,259
2021-06-02 2021-05-28 4 CVS CVS HEALTH Corp
Common Stock (restricted)
A - Award 34,706 34,706 86.44 2,999,987 2,999,987
2021-05-18 2021-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 379 1,105 52.20
2021-03-26 2021-03-24 4 TNET TRINET GROUP, INC.
Common Stock
A - Award 2,576 8,560 43.05
2021-03-17 2021-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 436 726 150.34
2020-11-17 2020-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 290 290
2020-09-24 3 DVA DAVITA INC.
No securities are beneficially owned
0
2020-03-27 2020-03-25 4 TNET TRINET GROUP, INC.
Common Stock
A - Award 5,773 5,984 2,736.02
2020-02-10 2020-02-06 4 TNET TRINET GROUP, INC.
Restricted Stock Units
M - Exercise -211 0 -100.00
2020-02-10 2020-02-06 4 TNET TRINET GROUP, INC.
Common Stock
M - Exercise 211 211
2020-01-17 2020-01-15 4 TNET TRINET GROUP, INC.
Restricted Stock Units
A - Award 211 211
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Restricted Stock Units
D - Sale to Issuer -23,940 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Performance Stock Units
D - Sale to Issuer -10,179 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Performance Stock Units
D - Sale to Issuer -23,780 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Stock Appreciation Rights
D - Sale to Issuer -81,864 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Stock Appreciation Rights
D - Sale to Issuer -55,376 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Stock Appreciation Rights
D - Sale to Issuer -11,415 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Stock Appreciation Rights
D - Sale to Issuer -25,715 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Common Stock
D - Sale to Issuer -635 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Common Stock
D - Sale to Issuer -25,000 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Common Stock
D - Sale to Issuer -11,174 0 -100.00
2018-11-28 2018-11-28 4 AET AETNA INC /PA/
Common Stock
D - Sale to Issuer -11,058 0 -100.00
2018-09-26 2018-09-24 4 AET AETNA INC /PA/
2015 Performance Stock Units
M - Exercise -1,546 0 -100.00
2018-09-26 2018-09-24 4 AET AETNA INC /PA/
Common Stock
F - Taxes -861 11,058 -7.22 203.40 -175,127 2,249,197
2018-09-26 2018-09-24 4 AET AETNA INC /PA/
Common Stock
M - Exercise 1,856 11,919 18.44
2018-09-26 2018-06-26 4 AET AETNA INC /PA/
Common Stock
G - Gift -2,500 46,237 -5.13
2018-03-06 2018-03-02 4 AET AETNA INC /PA/
Restricted Stock Units
A - Award 23,940 23,940
2018-03-06 2018-03-02 4 AET AETNA INC /PA/
Performance Stock Units
M - Exercise -10,448 0 -100.00
2018-03-06 2018-03-02 4 AET AETNA INC /PA/
Common Stock
F - Taxes -5,684 48,737 -10.44 177.53 -1,009,081 8,652,280
2018-03-06 2018-03-02 4 AET AETNA INC /PA/
Common Stock
M - Exercise 12,538 54,421 29.94
2017-12-21 2017-12-19 4 AET AETNA INC /PA/
Performance Stock Units
A - Award 1,546 1,546
2017-12-21 2017-12-19 4 AET AETNA INC /PA/
Performance Stock Units
A - Award 10,448 10,448
2017-12-21 2017-12-18 4 AET AETNA INC /PA/
Common Stock
G - Gift -3,000 41,883 -6.68
2017-03-23 2017-03-23 4 AET AETNA INC /PA/
Common Stock
S - Sale -8,434 44,880 -15.82 128.41 -1,083,009 5,763,036
2017-03-23 2017-03-22 4 AET AETNA INC /PA/
Stock Appreciation Rights
M - Exercise -27,688 55,376 -33.33 103.45 -2,864,324 5,728,647
2017-03-23 2017-03-22 4 AET AETNA INC /PA/
Stock Appreciation Rights
M - Exercise -51,431 25,715 -66.67 100.50 -5,168,816 2,584,358
2017-03-23 2017-03-22 4 AET AETNA INC /PA/
Common Stock
F - Taxes -70,685 53,314 -57.00 128.33 -9,071,006 6,841,786
2017-03-23 2017-03-22 4 AET AETNA INC /PA/
Common Stock
M - Exercise 27,688 123,999 28.75 103.45 2,864,324 12,827,697
2017-03-23 2017-03-22 4 AET AETNA INC /PA/
Common Stock
M - Exercise 51,431 96,311 114.60 100.50 5,168,816 9,679,256
2017-03-23 2017-03-22 4 AET AETNA INC /PA/
Common Stock
S - Sale -9,497 44,880 -17.47 128.61 -1,221,379 5,771,873
2017-03-23 2017-03-21 4 AET AETNA INC /PA/
Stock Appreciation Rights
M - Exercise -42,250 0 -100.00 72.26 -3,052,985
2017-03-23 2017-03-21 4 AET AETNA INC /PA/
Common Stock
F - Taxes -32,753 54,377 -37.59 129.09 -4,228,085 7,019,527
2017-03-23 2017-03-21 4 AET AETNA INC /PA/
Common Stock
M - Exercise 42,250 87,130 94.14 72.26 3,052,985 6,296,014
2017-03-23 2017-03-21 4 AET AETNA INC /PA/
Common Stock
S - Sale -11,671 44,880 -20.64 130.62 -1,524,514 5,862,410
2017-03-07 2017-03-03 4 AET AETNA INC /PA/
Performance Stock Units
M - Exercise -11,210 0 -100.00
2017-03-07 2017-03-03 4 AET AETNA INC /PA/
Common Stock
F - Taxes -10,752 56,551 -15.98 130.69 -1,405,179 7,390,650
2017-03-07 2017-03-03 4 AET AETNA INC /PA/
Common Stock
M - Exercise 22,420 67,303 49.95
2017-02-22 2017-02-17 4 AET AETNA INC /PA/
Stock Appreciation Rights
A - Award 81,864 81,864 125.27 10,255,103 10,255,103
2016-08-24 2016-08-23 4 AET AETNA INC /PA/
Common Stock
S - Sale -8,140 44,883 -15.35 120.31 -979,323 5,399,874
2016-08-24 2016-08-22 4 AET AETNA INC /PA/
Stock Appreciation Right
M - Exercise -40,000 42,250 -48.63 72.26 -2,890,400 3,052,985
2016-08-24 2016-08-22 4 AET AETNA INC /PA/
Common Stock
F - Taxes -31,860 53,023 -37.53 120.15 -3,827,979 6,370,713
2016-08-24 2016-08-22 4 AET AETNA INC /PA/
Common Stock
M - Exercise 40,000 84,883 89.12 72.26 2,890,400 6,133,646
2016-08-24 2016-08-22 4 AET AETNA INC /PA/
Common Stock
S - Sale -37,188 44,883 -45.31 120.19 -4,469,748 5,394,636
2016-02-23 2016-02-19 4 AET AETNA INC /PA/
Stock Appreciation Rights
A - Award 83,064 83,064
2016-02-03 2016-02-01 4 AET AETNA INC /PA/
Market Stock Units
M - Exercise -28,421 0 -100.00
2016-02-03 2016-02-01 4 AET AETNA INC /PA/
Common Stock
F - Taxes -19,054 82,071 -18.84 103.37 -1,969,612 8,483,679
2016-02-03 2016-02-01 4 AET AETNA INC /PA/
Common Stock
M - Exercise 42,632 101,125 72.88
2016-02-01 2016-01-28 4 AET AETNA INC /PA/
Performance Stock Units
A - Award 11,210 11,210
2015-09-28 2015-09-24 4 AET AETNA INC /PA/
Stock Appreciation Rights
A - Award 11,415 11,415
2015-03-16 2015-03-12 4 AET AETNA INC /PA/
Market Stock Units
M - Exercise -5,467 0 -100.00
2015-03-16 2015-03-12 4 AET AETNA INC /PA/
Common Stock
F - Taxes -3,991 58,493 -6.39 102.12 -407,561 5,973,305
2015-03-16 2015-03-12 4 AET AETNA INC /PA/
Common Stock
M - Exercise 8,201 62,484 15.11
2015-03-09 2015-03-02 4/A AET AETNA INC /PA/
Stock Appreciation Right
A - Award 77,146 77,146
2015-03-04 2015-03-02 4 AET AETNA INC /PA/
Stock Appreciation Right
A - Award 86,147 86,147
2015-02-04 2015-02-02 4 AET AETNA INC /PA/
Market Stock Units
M - Exercise -7,486 0 -100.00
2015-02-04 2015-02-02 4 AET AETNA INC /PA/
Performance Stock Units
M - Exercise -12,378 0 -100.00
2015-02-04 2015-02-02 4 AET AETNA INC /PA/
Common Stock
F - Taxes -5,385 54,283 -9.02 92.22 -496,605 5,005,978
2015-02-04 2015-02-02 4 AET AETNA INC /PA/
Common Stock
M - Exercise 11,229 59,668 23.18
2015-02-04 2015-02-02 4 AET AETNA INC /PA/
Common Stock
F - Taxes -6,111 48,439 -11.20 92.22 -563,556 4,467,045
2015-02-04 2015-02-02 4 AET AETNA INC /PA/
Common Stock
M - Exercise 16,011 54,550 41.54
2015-01-20 2015-01-15 4 AET AETNA INC /PA/
Performance Stock Units
A - Award 6,189 6,189
2014-03-14 2014-03-12 4 AET AETNA INC /PA/
Market Stock Units
M - Exercise -5,524 5,467 -50.26
2014-03-14 2014-03-12 4 AET AETNA INC /PA/
Performance Stock Units
M - Exercise -4,892 0 -100.00
2014-03-14 2014-03-12 4 AET AETNA INC /PA/
Common Stock
F - Taxes -4,032 38,539 -9.47 73.35 -295,747 2,826,836
2014-03-14 2014-03-12 4 AET AETNA INC /PA/
Common Stock
M - Exercise 8,286 42,571 24.17
2014-03-14 2014-03-12 4 AET AETNA INC /PA/
Common Stock
F - Taxes -2,391 34,285 -6.52 73.35 -175,380 2,514,805
2014-03-14 2014-03-12 4 AET AETNA INC /PA/
Common Stock
M - Exercise 4,912 36,676 15.46
2014-03-05 2014-03-03 4 AET AETNA INC /PA/
Stock Appreciation Right
A - Award 82,250 82,250
2014-02-05 2014-02-03 4 AET AETNA INC /PA/
Market Stock Units
M - Exercise -7,565 0 -100.00
2014-02-05 2014-02-03 4 AET AETNA INC /PA/
Performance Stock Units
M - Exercise -6,698 0 -100.00
2014-02-05 2014-02-03 4 AET AETNA INC /PA/
Common Stock
F - Taxes -3,861 31,764 -10.84 67.06 -258,919 2,130,094
2014-02-05 2014-02-03 4 AET AETNA INC /PA/
Common Stock
M - Exercise 11,348 35,625 46.74
2014-02-05 2014-02-03 4 AET AETNA INC /PA/
Common Stock
F - Taxes -2,740 24,277 -10.14 67.06 -183,744 1,628,016
2014-02-05 2014-02-03 4 AET AETNA INC /PA/
Common Stock
M - Exercise 6,726 27,017 33.15
2014-01-31 2014-01-29 4 AET AETNA INC /PA/
Performance Stock Units
A - Award 6,189 6,189
2014-01-31 2014-01-29 4 AET AETNA INC /PA/
Performance Stock Units
A - Award 2,446 2,446
2014-01-31 2014-01-29 4 AET AETNA INC /PA/
Performance Stock Units
A - Award 3,349 3,349
2013-03-13 2013-03-11 4 AET AETNA INC /PA/
Market Stock Units
M - Exercise -15,693 0 -100.00
2013-03-13 2013-03-11 4 AET AETNA INC /PA/
Performance Stock Units
M - Exercise -7,002 0 -100.00
2013-03-13 2013-03-11 4 AET AETNA INC /PA/
Common Stock
F - Taxes -7,445 20,291 -26.84 49.90 -371,506 1,012,521
2013-03-13 2013-03-11 4 AET AETNA INC /PA/
Common Stock
M - Exercise 17,862 27,736 180.90
2013-03-13 2013-03-11 4 AET AETNA INC /PA/
Common Stock
F - Taxes -7,130 9,874 -41.93 49.90 -355,787 492,713
2013-03-13 2013-03-11 4 AET AETNA INC /PA/
Common Stock
M - Exercise 14,004 17,004 466.80
2013-02-28 3 AET AETNA INC /PA/
Common Stock
3,000
2013-02-28 3 AET AETNA INC /PA/
Common Stock
358
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)